Page 85 - Read Online
P. 85

Page 14 of 16           Annibali et al. Mini-invasive Surg 2022;6:12  https://dx.doi.org/10.20517/2574-1225.2021.101

               32.      Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: results
                   from the multicenter international BASILICA registry. JACC Cardiovasc Interv 2021;14:941-8.  DOI  PubMed  PMC
               33.      Tarantini G, Fabris T, Nai Fovino L. TAVR-in-TAVR and coronary access: importance of preprocedural planning. EuroIntervention
                   2020;16:e129-32.  DOI  PubMed
               34.      Nai Fovino L, Scotti A, Massussi M, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the
                   risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc 2020;9:e016446.  DOI  PubMed  PMC
               35.      Tang GHL, Zaid S, Gupta E, et al. Feasibility of repeat tavr after SAPIEN 3 TAVR: a novel classification scheme and pilot
                   angiographic study. JACC Cardiovasc Interv 2019;12:1290-2.  DOI  PubMed
               36.      Akodad M, Sellers S, Gulsin GS, et al. Leaflet and neoskirt height in transcatheter heart valves: implications for repeat procedures and
                   coronary access. JACC Cardiovasc Interv 2021;14:2298-300.  DOI  PubMed
               37.      Tang GHL, Komatsu I, Tzemach L, et al. Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification.
                   EuroIntervention 2020;16:e757-9.  DOI  PubMed
               38.      Tarantini G, Fabris T, Cardaioli F, Nai Fovino L. Coronary access after transcatheter aortic valve replacement in patients with bicuspid
                   aortic valve: lights and shades. JACC Cardiovasc Interv 2019;12:1190-1.  DOI  PubMed
               39.      De Backer O, Landes U, Fuchs A, et al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography.
                   JACC Cardiovasc Interv 2020;13:2528-38.  DOI  PubMed
               40.      Bilkhu R, Jahangiri M, Otto CM. Patient-prosthesis mismatch following aortic valve replacement. Heart 2019;105:s28-33.  DOI
                   PubMed
               41.      Wendt D, Thielmann M, Plicht B, et al. The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic
                   bioprosthesis: is there a hemodynamic superiority? J Thorac Cardiovasc Surg 2014;147:1553-60.  DOI  PubMed
               42.      Herrmann HC, Daneshvar SA, Fonarow GC, et al. Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve
                   replacement: from the STS/ACC TVT registry. J Am Coll Cardiol 2018;72:2701-11.  DOI  PubMed
               43.      Vemulapalli S, Holmes DR Jr, Dai D, et al. Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: a report from
                   the STS/ACC TVT Registry. Am Heart J 2018;195:1-13.  DOI  PubMed
               44.      Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B. Prosthesis-patient mismatch predicts structural valve
                   degeneration in bioprosthetic heart valves. Circulation 2010;121:2123-9.  DOI  PubMed
               45.      Jie Yao R, Simonato M, Dvir D; Department of Cardiology, St Paul’s Hospital, Vancouver, Canada, Department of Cardiology, St
                   Paul’s  Hospital,  Vancouver,  Canada,  Department  of  Cardiology,  St  Paul’s  Hospital,  Vancouver,  Canada.  Optimising  the
                   haemodynamics of aortic valve-in-valve procedures. Interv Cardiol 2017;12:40.  DOI
               46.      Pibarot P, Simonato M, Barbanti M, et al. Impact of pre-existing prosthesis-patient mismatch on survival following aortic valve-in-
                   valve procedures. JACC Cardiovasc Interv 2018;11:133-41.  DOI  PubMed
               47.      Jilaihawi H, Chin D, Spyt T, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-
                   Corevalve bioprosthesis. Eur Heart J 2010;31:857-64.  DOI  PubMed
               48.      Simonato M, Webb J, Bleiziffer S, et al. Current generation balloon-expandable transcatheter valve positioning strategies during aortic
                   valve-in-valve procedures and clinical outcomes. JACC Cardiovasc Interv 2019;12:1606-17.  DOI  PubMed
               49.      Simonato M, Azadani AN, Webb J, et al. In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart
                   valves. EuroIntervention 2016;12:909-17.  DOI  PubMed
               50.      Azadani AN, Reardon M, Simonato M, et al. Effect of transcatheter aortic valve size and position on valve-in-valve hemodynamics: an
                   in vitro study. J Thorac Cardiovasc Surg 2017;153:1303-15.e1.  DOI  PubMed
               51.      Zenses AS, Evin MA, Stanová V, et al. Effect of size and position of self-expanding transcatheter valve on haemodynamics following
                   valve-in-valve procedure in small surgical bioprostheses: an in vitro study. EuroIntervention 2018;14:e282-9.  DOI  PubMed
               52.      Dvir D, Khan J, Kornowski R, et al. Novel strategies in aortic valve-in-valve therapy including bioprosthetic valve fracture and
                   BASILICA. EuroIntervention 2018;14:AB74-82.  DOI  PubMed
               53.      Grubitzsch H, Galloni M, Falk V. Wrinkles, folds and calcifications: reduced durability after transcatheter aortic valve-in-valve
                   replacement. J Thorac Cardiovasc Surg 2017;153:266-8.  DOI  PubMed
               54.      Allen KB, Chhatriwalla AK, Cohen DJ, et al. Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann
                   Thorac Surg 2017;104:1501-8.  DOI  PubMed
               55.      Saxon JT, Allen KB, Cohen DJ, Chhatriwalla AK. Bioprosthetic valve fracture during valve-in-valve TAVR: bench to bedside. Interv
                   Cardiol 2018;13:20-6.  DOI  PubMed  PMC
               56.      Chhatriwalla AK, Allen KB, Saxon JT, et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve
                   transcatheter aortic valve replacement. Circ Cardiovasc Interv 2017;10:e005216.  DOI  PubMed
               57.      Ziccardi MR, Groves EM. Bioprosthetic valve fracture for valve-in-valve transcatheter aortic valve replacement: rationale, patient
                   selection, technique, and outcomes. Interv Cardiol Clin 2019;8:373-82.  DOI  PubMed
               58.      Nielsen-Kudsk JE, Andersen A, Therkelsen CJ, et al. High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses
                   facilitates transcatheter aortic valve-in-valve implantation. EuroIntervention 2017;13:e1020-5.  DOI  PubMed
               59.      Patel JS, Krishnaswamy A, White J, et al. Optimizing hemodynamics of transcatheter aortic valve-in-valve implantation in 19-mm
                   surgical aortic prostheses. Catheter Cardiovasc Interv 2018;92:550-4.  DOI  PubMed
               60.      Tamagnini G, Bourguignon T, Rega F, et al. Device profile of the Inspiris Resilia valve for aortic valve replacement: overview of its
                   safety and efficacy. Expert Rev Med Devices 2021;18:239-44.  DOI  PubMed
               61.      Okamoto Y, Yamamoto K, Sugimoto T, Yoshii S. Early and late outcomes of AVR with aortic annular enlargement in octogenarian.
                   Gen Thorac Cardiovasc Surg 2015;63:453-8.  DOI  PubMed
   80   81   82   83   84   85   86   87   88   89   90